SynopsisThe global Tissue Engineered Bone market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Tissue Engineered Bone in various end use industries. The expanding.....
SynopsisSturge-Weber syndrome or Sturge-Weber-Krabbe disease, sometimes referred to as encephalotrigeminal angiomatosis, is a rare congenital neurological and skin disorder. It is one of the phakomatoses and is often associated with port-wine stains of the face, glauc.....
SynopsisIt is used to treat leukemia and certain types of cancer of the breast, skin, head and neck, or lung. The global Methotrexate Injection market was valued at US$ 155.2 million in 2023 and is anticipated to reach US$ 182.8 million by 2030, witnessing a CAG.....
SynopsisMedical air compression system is a device used to provide positive pressure air to support a patient's breathing or surgical anesthesia for a ventilator, anaesthesia machine, etc. The global Medical Air Compression System market was valued at US$ millio.....
SynopsisGlobal Ultrasonic Skin Cleaner market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have .....
SynopsisA bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recogn.....
Synopsis Global Dermatology Treatment Devices market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Ru.....
SynopsisInhaler can be taken in pocket. Inhalers also deliver medication more quickly. Global Inhalation Combination Product market is projected to reach US$ 17280 million in 2029, increasing from US$ 13470 million in 2022, with the CAGR of 3.7% during the perio.....
SynopsisTofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis The global Xeljanz (tofacitnib) Drug market was valued at US$ 1754 million in 2023 and is anticipated .....
SynopsisHemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attract.....
